The use of antidepressants during pregnancy and lactation;Uziti antidepresiv v tehotenstvi a v laktaci

Psychiatrie

Volumn 4, Issue 3, 2000, Pages 172-178

  Bares, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antidepressants; Lactation; Neonatal complications; Pregnancy; Teratogenic effects

Indexed keywords

ANTIDEPRESSANT AGENT;

BREAST FEEDING; DEPRESSION; DRUG USE; HUMAN; LACTATION; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK BENEFIT ANALYSIS; TERATOGENESIS; WITHDRAWAL SYNDROME;

EID: 0033693482     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Breastfeeding and sertraline: A 24-hour analysis
2. Pharmacologic management of psychiatric illness during pregnancy: Dillemmas and guidelines
3. Puerperal affective psychosis: Is there a case of lithium prophylaxis?
4. Amitriptyline in human breast milk and the nursing
5. Secretion of amitriptyline and metabolites into breast milk
6. Excretion of bupropion in breast milk
7. Amitriptyline and nortiptyline excretion in human breast milk
8. Birth outcomes in pregnant woman taking fluoxetine
9. Psychotropic drug use during pregnancy: Weighing the risks
10. Postpartum prophylaxis for women with bipolar disorder
11. Neonatal convulsions caused by withdraval from maternal clomipramine
12. Imipramine in pregnancy
13. Withdrawal symptoms in neonates associated with maternal imipramine therapy
14. Teratogenicity of psychotherapeutic medications
15. Delivery outcome after the use of antidepressants in early pregnancy
16. Tricyclics and breastfeeding
17. Small left colon syndrome associated with maternal ingestion of psychotropics
18. Effects of third trimester fluoxetine exposure on the newborn
19. Effects of first-trimester fluoxetine exposure on the newborn
20. Possible teratogenicity of imipraminechloropyramine
21. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk
22. Effects of antidepressants during pregnancy and lactation
23. Excretion of fluoxetine in human breast milk
24. Citalopram and desmethylcitalopram concentrations in breast milk and in serum of mother and infant
25. Excretion of doxepin and A-desmethyldoxepin in human milk
26. Epidemiology of puerperal psychoses
27. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)
28. Imipramine in pregnancy
29. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors; A prospective controlled multicenter study
30. Possible association between fluoxetinehydrochlorid and colic in an infant
31. Psychotropic medications in lactation
32. Sertraline and norsertraline in three breasted infants
33. Respiratory depression caused by A-desmethyldoxepin in breast milk
34. Limb deformities associated with ininodibenzyl hydrochloride
35. Tricyclic drugs in pregnancy and lactation: A preliminary record
36. Imipramine and congenital abnormalities
37. Postpartum mood disorders: Diagnosis and treatment guidelines
38. Neurodevelopment of children exposed in utero to antidepressant drugs
39. Prospective study of postpartum depression: Prevalence, course, and predictive factors
40. Rates and risk of postpartum depressiona meta-analysis
41. Controlled prospective study of postpartum mood disorders: Comparison of childbearing and nonchildbearing women
42. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)
43. Amitriptyline excretion in human milk
44. Moclobemide excretion in human breast milk
45. Effect of phenelzine and some related compounds in pregnancy
46. Principles of perinatal pharmacology
47. Postpartum psychosis in patients with manic depressive disease
48. Use of antidepressant drugs during the first trimester
49. Citalopram and breast-feeding: Serum concentration and side effects in the infant
50. Urinary retention in neonate secondary to maternal ingestion of nortriptyline
51. Toxic neonatal effects following maternal clomipramine therapy
52. Imipramine and pregnancy
53. Desimipramine and 2-hydroxydesimipramine in human milk and the nursing infant's serum
54. Prophylactic lithium in puerperal psychosis. The experience of three centres
55. Paroxetine in human breast milk and nursing infants
56. Psychopharmacology during pregnancy and lactation
57. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk
58. Withdrawal symptoms in neonates associated with maternal antidepressant therapy
59. Pharmacologic treatment of depression during pregnancy
60. Serum nortriptyline levels in nursing mothers and their infants
61. Serum sertraline and A-desmethylsertraline levels in breast-feeding mother-infant pairs
62. Antidepressant treatment during breast-feeding
63. Serum clomipramine and metabolite levels in four nursing mother-infant pairs
64. Tricyclics dose requirements
65. Excretion of fluvoxamine in breast milk